NCT01972867 - Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 13, 2021

Primary Completion Date

November 1, 2022

Study Completion Date

May 31, 2024

Conditions

Prostate Cancer

Interventions

DEVICE

NanoKnife Procedure

Subjects will be placed in the dorsal lithotomy position, under sterile technique. The NanoKnife procedure will be carried out under general anesthesia. A Foley catheter will be placed to aid in draining the bladder during treatment.

Trial Locations (2)

55905

Mayo Clinic, Rochester

60612

Rush University Medical Center, Chicago